Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Redefining Protein Interaction and Ubiquitination Researc...
2025-10-01
This thought-leadership article explores the mechanistic underpinnings and strategic value of the Influenza Hemagglutinin (HA) Peptide tag in translational research, with a focus on protein-protein interactions, ubiquitination, and posttranslational modification workflows. Drawing on recent evidence from cancer metastasis studies and cutting-edge HA tag protocols, we provide actionable guidance for researchers seeking to elevate their experimental designs and accelerate discovery.
-
GSK343: Unlocking EZH2 Inhibition for Functional Epigenet...
2025-09-30
Explore how GSK343, a selective EZH2 inhibitor, enables advanced mapping of functional epigenetic networks in cancer and stem cells. This article reveals unique strategies for dissecting PRC2-driven gene regulation and integrates the latest research on TERT expression and chromatin dynamics.
-
Influenza Hemagglutinin (HA) Peptide: Precision Tag for U...
2025-09-29
Explore how Influenza Hemagglutinin (HA) Peptide serves as an advanced molecular biology peptide tag for dissecting ubiquitin-mediated signaling and cancer metastasis. This article uniquely bridges HA tag peptide technology with mechanistic insights from current metastasis research.
-
Influenza Hemagglutinin (HA) Peptide: Revolutionizing Pro...
2025-09-28
Explore how the Influenza Hemagglutinin (HA) Peptide enables next-level protein complex analysis and mechanistic dissection in molecular biology. Discover unique strategies for leveraging this advanced HA tag peptide in ubiquitination and signaling research.
-
GSK343: A Next-Generation EZH2 Inhibitor for Epigenetic C...
2025-09-27
Explore the scientific foundations and advanced applications of GSK343, a selective EZH2 inhibitor pivotal for epigenetic cancer research. This article details its mechanism, unique selectivity, and emerging roles in understanding cancer biology.
-
Influenza Hemagglutinin (HA) Peptide: Advancing Precision...
2025-09-26
Explore how Influenza Hemagglutinin (HA) Peptide revolutionizes protein complex purification and quantitative interactomics. This in-depth guide reveals advanced methodologies and mechanistic insights, uniquely integrating competitive HA tag peptide elution with next-generation molecular biology workflows.
-
Torin 1: Advanced mTOR Inhibition for Cell Cycle and Lipi...
2025-09-25
Explore how Torin 1, a potent ATP-competitive mTOR inhibitor, enables cutting-edge research into mTOR signaling, cell proliferation inhibition, and interconnected lipid metabolic processes. This article uniquely synthesizes mechanistic detail and translational applications, offering insights distinct from prior reviews.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Redefining mRNA Delivery Sy...
2025-09-24
Discover how ARCA Cy5 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified and Cy5-labeled mRNA, uniquely empowers advanced mRNA delivery system research. This article explores its dual-fluorescence tracking, immune modulation, and pivotal role in translational pulmonary delivery studies.
-
PD 0332991 (Palbociclib) HCl: Dissecting Cell Death Pathw...
2025-09-23
PD 0332991 (Palbociclib) HCl, a selective CDK4/6 inhibitor, is pivotal in elucidating cell cycle G1 phase arrest and antiproliferative effects in breast cancer and multiple myeloma research. This article uniquely explores the intersection of CDK4/6 signaling, Rb phosphorylation inhibition, and recent advances in understanding cell death mechanisms beyond transcriptional repression.
-
br Disclosure br Acknowledgments br Introduction Anaplastic
2025-03-03

Disclosure Acknowledgments Introduction Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase, belongs to the insulin receptor kinase subfamily [1]. Oncogenic activation of ALK is associated with the wnt inhibitor and progression of multiple human cancer types [2,3], including anapl
-
Lipotoxicity is the accumulation of excess
2025-03-03

Lipotoxicity is the accumulation of excess lipids in non-adipose tissues that leads to cell dysfunction or cell death. It may play an important role in the pathogenesis of diabetes, and contributes to the rate of progression of CKD [7,8]. Emerging evidence indicates that renal lipid dysregulation is
-
ubiquitin activating enzyme The central problem in amnesia d
2025-03-03

The central problem in amnesia developing following impairment of long-term memory consolidation or reconsolidation is a question of the underlying mechanisms, whether it is caused by impairment of retrieval or memory storage mechanisms [3,8,9,[15], [16], [17], [18]]. To answer this question, severa
-
br Introduction Cell motility is fundamentally important in
2025-03-03

Introduction Cell motility is fundamentally important in morphogenesis, wound healing, and the immune response. One of the best-studied basic types of cell movement is lamellipodial motility [1, 2], characterized by a thin (∼0.1–0.2 μm), broad (∼10–40 μm) motile appendage containing a dynamic GSK
-
In conclusion two novel series of furo pyrimidin amines
2025-03-03

In conclusion, two novel series of furo[2,3-]pyrimidin4-amines and 7-pyrrolo[2,3-]pyrimidin-4-amines which exhibit potent in vitro inhibitor activity against ACK1 have been identified and evaluated. 1,3-Dithiolane-substituted pyrrolopyrimidine displays excellent ACK1 cellular inhibition, good kinas
-
The following are the supplementary data
2025-03-03

The following are the supplementary data related to this article. Conflict of interest Acknowledgements Disclosure of interest Introduction Since the introduction of platinum-based chemotherapy, metastatic testicular cancer has become a curable disease and most testicular cancer patient
16702 records 18/1114 page Previous Next First page 上5页 1617181920 下5页 Last page